Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study
View ORCID ProfileAwadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma, Kingshuk Bhattacharjee, Ritu Singh
doi: https://doi.org/10.1101/2021.04.07.21255078
Awadhesh Kumar Singh
1Consultant Endocrinologist, G. D Hospital & Diabetes Institute, Kolkata, West Bengal, India
MD, DMSanjeev Ratnakar Phatak
2Consultant Physician & Diabetologist, Vijayratna Diabetes Centre, Ahmedabad, Gujarat, India
MDNagendra Kumar Singh
3Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India
MDArvind Gupta
4Head, Department of Diabetes, Obesity and Metabolic Disorders, Rajasthan Hospital, Jaipur, Rajasthan, India
MDArvind Sharma
5Associate Professor, Dept. of Community Medicine, Mahatma Gandhi Medical College & Hospital, Jaipur, Rajasthan, India
MDKingshuk Bhattacharjee
6Independent Biostatistician, Kolkata, West Bengal, India
PhDRitu Singh
7Consultant Gynecologists, G. D Hospital & Diabetes Institute, Kolkata, West Bengal, India
MDData Availability
All the authors are responsible for the originality of this study. Original data can be shared from first author if necessary, after a reasonable request.
Posted April 13, 2021.
Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study
Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma, Kingshuk Bhattacharjee, Ritu Singh
medRxiv 2021.04.07.21255078; doi: https://doi.org/10.1101/2021.04.07.21255078
Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study
Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma, Kingshuk Bhattacharjee, Ritu Singh
medRxiv 2021.04.07.21255078; doi: https://doi.org/10.1101/2021.04.07.21255078
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4364)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2813)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6721)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)